(FOOL GLOBAL WIRE) LEXINGTON, Ky. (July 2): It was a light day for IFG stock news and the portfolio was mixed ahead of the second day of the Fed meeting and the start of earnings season. The Nasdaq slipped a half a percentage point following a quick bounce-back over the past few sessions.
Medtronic <% if gsSubBrand = "aolsnapshot" then Response.Write("(NYSE:MDT)") else Response.Write("(NYSE:MDT)") end if %> announced today that the FDA has cleared its Micro Jewel implantable defibrillator for commercial use.
Computer Associates <% if gsSubBrand = "aolsnapshot" then Response.Write("(NYSE:CA)") else Response.Write("(NYSE:CA)") end if %> announced a sever-year licensing agreement with First Data Corp. The financial terms weren't disclosed but a First Data spokesperson claimed that the agreement was the largest such pact in its history and that it expects the CA business software to reduce its operational costs "dramatically."
The most significant news on the day (although it barely moved the stock price) belonged to one of the IFG Relative Strength stocks (and soon to be included in the IFG Classic model if the rankings don't change), Paychex <% if gsSubBrand = "aolsnapshot" then Response.Write("(NASDAQ:PAYX)") else Response.Write("(NASDAQ:PAYX)") end if %>. Former Fool Portfolio short (they probably wish I'd stop referring to Chexy that way), Paychex posted record net income for the year ended May 31, 1996, a 34% increase over the previous year. Revenue was up 22% for the year.
For the fourth quarter, earnings climbed 38% to $0.21 per share versus $0.15 a share last year. Consensus estimates called for Paychex to earn $0.20 a share, so the penny surplus represents an earnings surprise of 5%. The stock slipped an eighth on the day.
Transmitted: 7/2/96 | ||||||||
INVESTING FOR GROWTH MODEL (7/2/96) | ||||||||
| ||||||||